Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A comprehensive approach to faculty development.

Bradley A Boucher1, Peter J Chyka, Walter L Fitzgerald

  • 1College of Pharmacy, University of Tennessee Health Science Center.

American Journal of Pharmaceutical Education
|December 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel microtubule inhibitor modulates the myeloid PD-L1 expression, restores T cell effector function, and promotes apoptosis for effective suppression of colorectal cancer.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

QW-5-70 targets the colchicine site and demonstrates antitumor activity in P-gp-overexpressing cancer models.

Molecular cancer therapeutics·2026
Same author

Preventing Dropped Balls: Pharmacists Can Catch Missed Opportunities in Lipid Management.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

A novel colchicine-binding site inhibitor suppresses triple-negative breast cancer growth and metastasis and synergizes with anti-PD-L1 immunotherapy in an immunogenic cancer model.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

VERU-111 Promotes an Anti-Tumor Response Through Restoration of Gut Microbial Homeostasis and Associated Metabolic Dysregulation.

Cells·2026
Same author

A Pyrimidine-Based Tubulin Inhibitor Shows Potent Anti-Glioblastoma Activity In Vitro and In Vivo.

Pharmaceuticals (Basel, Switzerland)·2025

Three faculty development programs were implemented to support academic growth. These initiatives, focusing on individual needs, research funding, and technology, received positive faculty feedback and showed promising outcomes in scholarly activities and education.

Area of Science:

  • Pharmacy Education
  • Faculty Development
  • Academic Pharmacy

Background:

  • Faculty development is critical for academic institutions.
  • The University of Tennessee's Faculty Development Committee (FDC) identified a need for enhanced faculty support.
  • Existing support structures required complementary programs to address diverse faculty needs.

Purpose of the Study:

  • To describe the development and implementation of three complementary faculty development programs.
  • To assess the initial outcomes and faculty reception of these new programs.
  • To offer these programs as a model for other academic pharmacy institutions.

Main Methods:

  • The Individual Faculty Development Program encouraged self-assessment of needs.
  • The Seed Research Grant Program provided funding for faculty scholarly activities.

Related Experiment Videos

  • The Technology Support Program offered financial assistance for technology upgrades.

    • Main Results:

    • Eighteen faculty members participated in the Individual Faculty Development Program with positive feedback.
    • The Seed Research Grant Program funded six projects in its first year.
    • Early data indicate favorable outcomes in grant submissions, publications, and educational offerings.

    Conclusions:

    • The three programs offer faculty a high degree of self-determination in their professional growth.
    • These initiatives demonstrate a successful approach to fostering academician development.
    • Other pharmacy colleges are encouraged to adopt similar faculty development strategies.